GKB Ophthalmics Share Price Today

GKB Ophthalmics reappoints K.G. Gupta as CMD for three years

Shareholders unanimously approved K.G. Gupta's re-appointment as CMD for three years starting April 1, 2027. No dividend declared for FY26 due to operating losses; net worth stands at ₹12.89 crore. Cedric Lobo re-appointed as Executive Whole Time Director for two years with remuneration up to ₹15.00 lakh p.a. Related party transaction limits approved for GKB Vision Private Limited and Lensco - The Lens Company.

Hexiris Ophthalmics to present first-in-human glaucoma data at five meetings

Hexiris Ophthalmics will present first-in-human data for its OBi glaucoma platform at five major meetings starting September 10. Eleven eyes treated with OBi Core showed no adverse events, with postoperative pressures ranging from single digits to low teens. The platform aims to shift glaucoma surgery from operating rooms to slit-lamp settings to improve patient access. Commercial launch of OBi Core and OBi Gon is planned for select markets in early 2027, pending regulatory approvals.

GKB Ophthalmics shareholders unanimously approve all seven AGM resolutions

GKB Ophthalmics shareholders unanimously approved all seven resolutions at its 44th AGM on August 25, 2026. Key approvals included re-appointments of K.G. Gupta, Cedric Lobo, and Vikram Gupta to the board. Promoter group voted 100% in favour across all resolutions, with varying levels of participation. Public institutional investors held 90,000 shares but did not cast any votes during the meeting. Total shareholder base stood at 2,602 as on the record date of August 18, 2026.

GKB Ophthalmics holds 44th AGM on Aug 25 with no dividend

GKB Ophthalmics conducts its 44th AGM on August 25, 2026, in Mapusa, Goa. The company proposes no dividend for FY25-26. Share transfer books close from August 19-25, with e-voting available until August 24.

GKB Ophthalmics receives Rs 8.82 Cr demand notice from Labour Commissioner

GKB Ophthalmics Ltd received a Notice of Demand on July 13, 2026, for Rs 8.82 Cr following a Labour Commissioner order dated September 04, 2025. The company plans to challenge the order in the Bombay High Court. The demand is linked to a 2021 Industrial Tribunal award currently under litigation.

Promoter group buys shares in GKB Ophthalmics worth ₹64,801.77

Krishna Gopal Gupta & Sons (HUF), a promoter group entity, purchased 1,016 equity shares of GKB Ophthalmics Limited between June 8 and June 17, 2026. The transactions were executed on the BSE for an aggregate value of ₹64,801.77. The entity has agreed to hold the securities for a minimum period of six months.